MERIDIAN DIAGNOSTICS INC
10-Q, EX-27, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MERIDIAN DIAGNOSTICS INC, 10-Q, 2000-08-14
Next: MERIDIAN DIAGNOSTICS INC, 10-Q, EX-99, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              SEP-30-2000
<PERIOD-START>                                 OCT-01-1999
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         4,984
<SECURITIES>                                   1,002
<RECEIVABLES>                                  14,695
<ALLOWANCES>                                   402
<INVENTORY>                                    11,638
<CURRENT-ASSETS>                               33,093
<PP&E>                                         24,647
<DEPRECIATION>                                 11,295
<TOTAL-ASSETS>                                 71,150
<CURRENT-LIABILITIES>                          12,164
<BONDS>                                        20,000
                          0
                                    0
<COMMON>                                       2,529
<OTHER-SE>                                     31,548
<TOTAL-LIABILITY-AND-EQUITY>                   34,077
<SALES>                                        43,246
<TOTAL-REVENUES>                               43,246
<CGS>                                          16,016
<TOTAL-COSTS>                                  16,016
<OTHER-EXPENSES>                               17,752
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             1,543
<INCOME-PRETAX>                                8,564
<INCOME-TAX>                                   3,361
<INCOME-CONTINUING>                            5,203
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   5,203
<EPS-BASIC>                                  0.36
<EPS-DILUTED>                                  0.36



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission